Your browser doesn't support javascript.
loading
CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.
Morisaka, Hiroyuki; Yoshimi, Kazuto; Okuzaki, Yuya; Gee, Peter; Kunihiro, Yayoi; Sonpho, Ekasit; Xu, Huaigeng; Sasakawa, Noriko; Naito, Yuki; Nakada, Shinichiro; Yamamoto, Takashi; Sano, Shigetoshi; Hotta, Akitsu; Takeda, Junji; Mashimo, Tomoji.
Afiliação
  • Morisaka H; Department of Genome Biology, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
  • Yoshimi K; Department of Dermatology, Kochi Medical School, Kochi University, Kochi, 783-8505, Japan.
  • Okuzaki Y; Genome Editing Research and Development Center, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
  • Gee P; Institute of Experimental Animal Sciences, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
  • Kunihiro Y; Division of Animal Genetics, Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.
  • Sonpho E; Center for iPS Cell Research and Application (CiRA), Department of Clinical Application, Kyoto University, Kyoto, 606-8507, Japan.
  • Xu H; Center for iPS Cell Research and Application (CiRA), Department of Clinical Application, Kyoto University, Kyoto, 606-8507, Japan.
  • Sasakawa N; Genome Editing Research and Development Center, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
  • Naito Y; Institute of Experimental Animal Sciences, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
  • Nakada S; Department of Biology, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.
  • Yamamoto T; Center for iPS Cell Research and Application (CiRA), Department of Clinical Application, Kyoto University, Kyoto, 606-8507, Japan.
  • Sano S; Center for iPS Cell Research and Application (CiRA), Department of Clinical Application, Kyoto University, Kyoto, 606-8507, Japan.
  • Hotta A; Database Center for Life Science, Mishima, 411-8540, Japan.
  • Takeda J; National Institute of Genetics, Mishima, 411-8540, Japan.
  • Mashimo T; Institute for Advanced Co-Creation Studies, Osaka University, Osaka, 565-0871, Japan.
Nat Commun ; 10(1): 5302, 2019 12 06.
Article em En | MEDLINE | ID: mdl-31811138
Although single-component Class 2 CRISPR systems, such as type II Cas9 or type V Cas12a (Cpf1), are widely used for genome editing in eukaryotic cells, the application of multi-component Class 1 CRISPR has been less developed. Here we demonstrate that type I-E CRISPR mediates distinct DNA cleavage activity in human cells. Notably, Cas3, which possesses helicase and nuclease activity, predominantly triggered several thousand base pair deletions upstream of the 5'-ARG protospacer adjacent motif (PAM), without prominent off-target activity. This Cas3-mediated directional and broad DNA degradation can be used to introduce functional gene knockouts and knock-ins. As an example of potential therapeutic applications, we show Cas3-mediated exon-skipping of the Duchenne muscular dystrophy (DMD) gene in patient-induced pluripotent stem cells (iPSCs). These findings broaden our understanding of the Class 1 CRISPR system, which may serve as a unique genome editing tool in eukaryotic cells distinct from the Class 2 CRISPR system.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Associadas a CRISPR / Sistemas CRISPR-Cas / Edição de Genes Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Associadas a CRISPR / Sistemas CRISPR-Cas / Edição de Genes Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article